Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)

China · Delayed Price · Currency is CNY

6.44

+0.03 (0.47%)

Sep 30, 2026, 4:00 PM EDT

SHA:688189 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	136.13	141.93	251.72	720.06	698.83	743.66
Revenue Growth	38.56%	-43.62%	-65.04%	3.04%	-6.03%	-27.74%
Gross Profit	21.59	37.21	122.12	598.53	580.98	640.23
Operating Income	-94.05	-101.02	-347.98	4.33	-79.6	-216.46
Net Income	-134.06	-136.9	-346.51	-10.87	-78.83	-161.88
Earnings Per Share	-0.49	-0.50	-1.26	-0.04	-0.29	-0.59
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	347.18	301.52	490.27	665.76	713.47	730.67
Total Debt	60.02	10.03	219.12	324.6	543.65	475.38
Net Cash (Debt)	287.16	291.49	271.15	341.16	169.82	255.29
Net Cash Growth	-1.40%	7.50%	-20.52%	100.89%	-33.48%	-58.59%
Net Cash Per Share	1.05	1.06	0.99	1.24	0.62	0.93

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	20.74	114.57	1.39	215.23	-160.09	-63.11
Capital Expenditures	-33.82	-79.8	-58.43	-31.49	-41.01	-113.59
Free Cash Flow	-13.08	34.77	-57.03	183.74	-201.1	-176.7
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	15.86%	26.22%	48.51%	83.12%	83.14%	86.09%
Operating Margin	-69.09%	-71.18%	-138.24%	0.60%	-11.39%	-29.11%
Pretax Margin	-95.33%	-93.53%	-149.64%	-1.27%	-10.59%	-28.88%
Profit Margin	-98.48%	-96.46%	-137.65%	-1.51%	-11.28%	-21.77%
FCF Margin	-9.61%	24.50%	-22.66%	25.52%	-28.78%	-23.76%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	21.23	21.23	21.23	21.23	21.23
P/FCF Ratio	-	62.48	-	14.08	-	-
PS Ratio	12.91	15.31	7.09	3.59	4.84	6.63